UNIVERSITY OF NORTH CAROLINA HOSPITALS
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1989-01-01
- Employees
- -
- Market Cap
- -
Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2006-06-07
- Last Posted Date
- 2016-12-23
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT00334438
- Locations
- 🇺🇸
Hackensack University Medical Center Cancer Center, Hackensack, New Jersey, United States
🇺🇸Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 41
- Registration Number
- NCT00320073
- Locations
- 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
- Conditions
- First Posted Date
- 2006-04-10
- Last Posted Date
- 2012-05-01
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Registration Number
- NCT00312637
- Locations
- 🇺🇸
Mammography Clinic - UNC Hospitals, Chapel Hill, North Carolina, United States
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors
- Conditions
- First Posted Date
- 2006-03-27
- Last Posted Date
- 2012-04-04
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT00307255
- Locations
- 🇺🇸
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim
- Conditions
- First Posted Date
- 2006-01-23
- Last Posted Date
- 2013-02-05
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT00280787
- Locations
- 🇺🇸
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC
- First Posted Date
- 2006-01-23
- Last Posted Date
- 2017-07-11
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 75
- Registration Number
- NCT00280735
- Locations
- 🇺🇸
University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2006-01-20
- Last Posted Date
- 2017-06-19
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 46
- Registration Number
- NCT00280150
- Locations
- 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
🇺🇸Batte Cancer Center at Northeast Medical Center, Concord, North Carolina, United States
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
- First Posted Date
- 2005-12-15
- Last Posted Date
- 2012-03-07
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 23
- Registration Number
- NCT00266097
- Locations
- 🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
- Conditions
- First Posted Date
- 2005-11-22
- Last Posted Date
- 2012-02-14
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 31
- Registration Number
- NCT00257426
- Locations
- 🇺🇸
The University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
- First Posted Date
- 2005-10-30
- Last Posted Date
- 2017-06-28
- Lead Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Target Recruit Count
- 29
- Registration Number
- NCT00246753
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
🇺🇸Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸Rex Cancer Center at Rex Hospital, Raleigh, North Carolina, United States